Higher Coverage of Select Mammals

National Human Genome Research Institute

National Institutes of Health
U.S. Department of Health and Human Services


Higher Coverage of Select Mammals

Initiative Rationale

While low-redundancy (2X) whole genome sequencing of mammals has provided a broad resource for scientists interested in comparative human genome annotation, there are limits to its utility. For example, if an organism is an experimental biomedical model system, the community will often require a high-quality genome assembly.

In addition, a high-quality assembly is useful for investigating a number of questions, including:

Further information on this initiative is available in the white paper see: Increasing sequence coverage from 2x to high coverage (6-7x) for selected mammalian species.

Top of page

Active Sequencing Projects

For an updated list of the genomes that are actively being sequenced or that have been completed recently, please see Approved Sequencing Targets.

Top of page

Program Contacts

Adam Felsenfeld, Ph.D.
Program Director
E-mail: felsenfa@mail.nih.gov

Jane Peterson, Ph.D.
Associate Director, Division of Extramural Research
E-mail: petersoj@mail.nih.gov

To view the PDF on this page you will need Adobe Acrobat Reader. Download Adobe Acrobat Reader

Top of page

Last Reviewed: June 13, 2012